Ashley Gilliland

ORCID: 0000-0003-0616-0956
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Escherichia coli research studies
  • Salmonella and Campylobacter epidemiology
  • Mycobacterium research and diagnosis
  • Gut microbiota and health
  • Gastric Cancer Management and Outcomes
  • Vibrio bacteria research studies
  • Dermatology and Skin Diseases
  • Oral health in cancer treatment
  • Advanced Drug Delivery Systems
  • Antibiotic Resistance in Bacteria
  • Inflammatory Bowel Disease
  • Probiotics and Fermented Foods
  • Microscopic Colitis
  • Inhalation and Respiratory Drug Delivery

University of British Columbia
2023-2025

British Columbia Children's Hospital
2023

University of Alberta
2022

Abstract NOT PUBLISHED AT THE AUTHOR’S REQUEST Funding Agencies: None

10.1093/jcag/gwae059.022 article EN cc-by Journal of the Canadian Association of Gastroenterology 2025-02-01

Abstract NOT PUBLISHED AT AUTHOR’S REQUEST Please acknowledge all funding agencies listed below Funding Agencies: CCC, CIHRWeston Family Foundation

10.1093/jcag/gwae059.005 article EN cc-by Journal of the Canadian Association of Gastroenterology 2025-02-01

Citrobacter rodentium is an attaching and effacing (A/E) pathogen used to model enteropathogenic enterohemorrhagic Escherichia coli infections in mice. During colonization, C. must adapt stresses the gastrointestinal tract, such as antimicrobial peptides, pH changes, bile salts. The Cpx envelope stress response (ESR) a two-component system by some bacteria remediate modulating gene expression, it necessary for pathogenesis Here, we utilized simulated colonic fluid (SCF) mimic environment,...

10.1128/iai.00314-22 article EN Infection and Immunity 2022-08-24

Abstract Background Inflammatory bowel disease (IBD) pathobionts are commensal microbes with pathogenic potential that may cause or exacerbate IBD symptoms. Some (ex. Escherichia coli) reside at low levels in the lumen of a healthy gut but can rapidly grow inflamed colons ulcerative colitis (UC) patients. To promote disease, these must cross colonic mucus barrier (comprised MUC2) separates epithelium from luminal microbes. It is currently unclear how bacterial UC Aims Using and patient...

10.1093/jcag/gwad061.024 article EN cc-by Journal of the Canadian Association of Gastroenterology 2024-02-14

Abstract Citrobacter rodentium is an attaching and effacing (A/E) pathogen used to model enteropathogenic enterohemorrhagic Escherichia coli infections in mice. During colonization, C. must adapt stresses the gastrointestinal tract such as antimicrobial peptides, pH changes, bile salts. The Cpx envelope stress response (ESR) a two-component system by some bacteria remediate modulating gene expression necessary for pathogenesis Here, we utilized simulated colonic fluid (SCF) mimic environment...

10.1101/2022.08.05.503015 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2022-08-06

Abstract Citrobacter rodentium is an attaching and effacing (A/E) pathogen used as a model for enteropathogenic enterohemorrhagic Escherichia coli infections in mice. While the host, C. must adapt to stresses gastrointestinal tract such antimicrobial peptides, pH changes, bile salts. The Cpx envelope stress response (ESR) two-component system by some bacteria remediate modulating gene expression necessary pathogenesis To investigate genes regulon that may contribute pathogenesis, RNA-Seq,...

10.1101/2021.12.13.472529 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2021-12-14
Coming Soon ...